Advanced Therapies Europe 2025

Over the course of three days, Advanced Therapies Europe 2025 transformed the Hotel Arts in Barcelona into a meeting point for 500 advanced therapies professionals, the majority of whom came from across Europe (55%), with nearly a third representing local and national stakeholders (27%). These figures confirmed the growing role of the Catalan capital as a European hub in this field.

The presence of the BioRegion was particularly prominent in the program, with strong participation from companies and institutions linked to the ATMP Catalonia initiative. Among the speakers were representatives from Invivo Partners, Ysios Capital, Asabys Partners, SpliceBio, Inveready, Integra Therapeutics, Sant Joan de Déu Hospital, Biocat, OneChain Therapeutics, Hospital Clínic de Barcelona, the Blood and Tissue Bank, and Gyala Therapeutics — a reflection of the growing diversity and maturity of the Catalan ecosystem in this area.

Over three days of expert content, strategic networking, and invitation-only summits, Advanced Therapies Europe 2025 brought together therapy developers, pharmaceutical leaders, CDMOs, and investors in a focused and unique environment.

From plenary sessions and technical workshops to the Women in Advanced Therapies Congress and the Investment Summit, every element was designed to accelerate innovation, investment, and commercialization in the field of advanced therapies.

Whether you're launching a new therapy, seeking strategic partnerships, or staying ahead of regulatory and market shifts, Advanced Therapies Europe is built to deliver actionable insight and meaningful connections.

• Expand Your Network – Meet biotech CEOs, pharma strategists, CDMO leaders, and investors shaping the next wave of therapeutic innovation.
   
• Gain Strategic Insight – Access sessions led by industry experts on regulation, funding trends, scale-up solutions, and commercial strategy.
   
• Discover What’s Next – Explore the latest advances in cell and gene therapy platforms, biotech technologies, and regenerative medicine.

Fireside chat: From Seed to scale – How we built an investor-ready biotech

A candid conversation between a biotech founder and their early investor exploring the startup journey.

02/09/2025

10:50 AM - 11:20 AM

Hotel Arts, Barcelona (Spain)

Speakers:

• Sylvain Sachot, Partner. Asabys Partners
• Miquel Vila-Perelló, CEO. Splice Bio
   

Panel: Trends talk – Emerging hotspots in biotech investing

A rapid-fire panel / multi-perspective session on high-growth areas in biotech. Each speaker gives a 5-minute outlook on where their focus and how this aligns with market trends.

02/09/2025

12:10 AM - 12:50 AM

Hotel Arts, Barcelona (Spain)

Chairperson:

• Antonio Herce, Director. Inveready

Speakers:

• Artemy Shumisky, Senior Associate. LongeVC
• Luis Pareras, Managing Partner. Invivo Partners
• Ilya Yasny, Partner. LanceBio Ventures
   

Opening Panel: Rethinking access and advancement within the advanced therapies industry

Explore the complex mix of visible and invisible barriers that shape entry into the industry. Address systemic challenges and how we can create a truly inclusive workforce.

02/09/2025

2:05 PM - 2:45 PM

Hotel Arts, Barcelona (Spain)

Chairperson:

• Terri Gaskell, CTO. Rinri Therapeutics

Speakers:

• Avencia Sanchez-Mejias, CEO & Co-founder. Integra Therapeutics
• Keren Leshem, CEO & Interim Chair. OCON Therapeutics
• Kat Kozyrytska, Founder. Cell Therapy Manufacturability Program
• Mayra Battilani, Former EMEA – Commercial Strategy Director Gene Therapy – Rare Diseases. Johnson & Johnson
   

Roundtable 5: How to be a good mentor – and find one

02/09/2025

3:05 PM - 3:50 PM

Hotel Arts, Barcelona (Spain)

Speakers:

• Alessandra Magnani, Head of the Advanced Therapies and Immunotherapy Platform. Hospital Sant Joan de Déu
   

Panel: The state of the CGT industry & turning the future into action 

This session will explore the current state of the CGT industry, with a focus on Europe’s evolving role amid global shifts. In a climate where research ecosystems face mounting uncertainty — particularly following moves in the U.S. to scale back federal support for scientific innovation, Europe must sharpen its competitiveness to secure its leadership in advanced therapies. 

03/09/2025

9:10 AM - 9:55 AM

Hotel Arts, Barcelona (Spain)

Chairperson:

• Anthony Davies, Founder & CEO. Dark Horse Consulting

Speakers:

• Thomas Carlsen, CEO. Novo Nordisk Cellerator
• Marion Hitchcock, Managing Director Gene & Cell Therapies Incubator Berlin. Bayer
• Claire Skentelbery, CEO. EuropaBio
• Montse Daban, Strategic Foresight and International Relations Director. Biocat
• Angela Vollstedt, Global Portfolio Director of Cell and Gene Therapies. Novartis

Panel: Is decentralized manufacturing the path to profitability?

Analyzes the economic realities behind the trend toward decentralization.

03/09/2025

11:10 AM – 11:45 AM

Hotel Arts, Barcelona (Spain)

Moderator:

• Montse Daban, Director of Strategic Analysis and International Relations. Biocat

Speakers:

• Noelia Mateo, Global Director of Advanced Therapies, Business and Strategy. Hospital Clínic de Barcelona
   

Panel: From discovery to development – Creating realistic CGT timelines

The transition from academic scientific concept to market-ready product requires biotech teams to integrate CMC, regulatory, and pharmacology considerations from the outset, thereby avoiding the pitfalls of overselling and overpromising.

03/09/2025

2:15 PM - 2:55 PM

Hotel Arts, Barcelona (Spain)

Chairperson:

• Andrew Frazer, Associate Director, Scientific Solutions. Charles River Laboratories

Speakers:

• Anne Douar, Principal & Founder. Ad hoc Biologics
• Elena Matsa, teacher. University College Cork
• Alessandra Magnani, Head of the Advanced Therapies and Immunotherapy Platform. Hospital Sant Joan de Déu
• Claudio Santos, CEO. Gyala Therapeutics

Spain’s biotech leap: Manufacturing, clinical capacity & EU integration

Exploration Spain’s growing potential as a strategic ATMP manufacturing and clinical trial hub within the EU.

03/09/2025

4:30 PM - 5:40 PM

Speakers:

• Stefanos Theoharis, Chief Executive Officer. OneChain Therapeutics
• Claudio Santos, CEO. Gyala Therapeutics
• Angel Lucio, CEO.  TETRANEURON
• Núria Gavaldà, Strategy Director. ATMP Platform, Banc de Sang i Teixits
• Montse Daban, Executive Director. BIOCAT

Panel: The reality of raising funds for CGT startups

Today's CGT startups are facing the toughest fundraising environment in years — and solid science alone isn’t enough. This panel digs into the hard truths: How the market squeeze is reshaping funding dynamics, why traditional playbooks aren't working, and what it takes to stand out when investors are more selective than ever. Real stories. Real setbacks. Real strategies for surviving and scaling in a high-stakes market. 

04/09/2025

10:15 AM - 11:00 AM

Hotel Arts, Barcelona (Spain)

Chairperson:

• Kerstin Papenfuss, Director Pharma. Deep Science Ventures

Speakers:

• Armin Nowack, Senior Vice President Business Development. Swissfinity Group
• Thomas Harth, Partner. Ysios Capital
• Sven Kili, Partner. Saisei Ventures

Building Europe’s Policy Pathway for Advanced Therapies

This is a closed-door, outcome-driven discussion bringing together senior leaders to align on immediate, practical steps that can accelerate policy evolution, strengthen the European ATMP ecosystem, and unlock scalable patient access. 

04/09/2025

11:30 AM - 11:45 AM

Hotel Arts, Barcelona (Spain)

Speakers: 

• Claire Skentelbery, Director General. EuropaBio
• Andrea Traube, CEO. KyooBe Tech GmbH
• Jimmy Vanhove, CEO. Viralgen

Spotlight: Development of autologous and iPSC-derived allogeneic products for leukaemia and solid cancer

04/09/2025

11:45 AM - 12:00 AM

Hotel Arts, Barcelona (Spain)

Speaker: 

• Stefanos Theoharis, Chief Executive Officer. OneChain Therapeutics

   

Panel: Charting the way forward: Where are we heading?

As we wrap up two days of deep discussions on the current state of the European CGT landscape, this final panel will chart the path ahead. Which steps must Europe take to remain competitive and lead the way in the next 5–10 years? Each panellist will share their key takeaways from the last two days, reflecting on the insights, challenges, and opportunities discussed. 

04/09/2025

3:05 PM - 3:40 PM

Hotel Arts, Barcelona (Spain)

Chairperson:

• Montse Daban, Strategic Foresight and International Relations Director. Biocat

Speakers:

• Angela Vollstedt, Director Global Cell & Gene Therapies Portfolio. Novartis
• Miguel Forte, Chief Executive Officer & President, ISCT. Kiji Therapeutics
• Raphael Ognar,  Chief Executive Officer. NKILT Therapeutics
• Bernd Eschgfäller, Independent Board Member. T-CURX

20% discount for companies and organizations in the BioRegion of Catalonia using the code BIOCAT20 at registration

 And we’re thrilled to share that the next edition of Advanced Therapies Europe will also take place in Barcelona!